Performance

Quarter-End

as of March 31, 2021
Our Funds Q1'21 YTD 1YR 3YR 5YR 10YR Since Inception2 Inception Date Net Expense Ratio Gross Expense Ratio1
CRM Long/Short Opportunities  
CRIHX - Institutional Shares 1.82% 1.82% 33.00% 8.34% 6.05% August 16, 2016 2.96% 3.04%
S&P 500 Index 6.17% 6.17% 56.35% 16.78% 16.12%
CRM Small Cap Value  
CRISX - Institutional Shares 15.30% 15.30% 81.89% 7.46% 10.87% 8.76% 9.07% January 27, 1998 0.93% 0.93%
CRMSX - Investor Shares 15.24% 15.24% 81.45% 7.21% 10.62% 8.52% 10.46% October 1, 1995 1.17% 1.17%
Russell 2000 Value Index 21.17% 21.17% 97.05% 11.57% 13.56% 10.06% 10.10%
CRM Small/Mid Cap Value  
CRIAX - Institutional Shares 13.50% 13.50% 82.62% 14.39% 14.59% 10.74% 10.32% September 1, 2004 0.96% 0.96%
CRMAX - Investor Shares 13.44% 13.44% 82.13% 14.12% 14.35% 10.51% 10.09% September 1, 2004 1.18% 1.18%
Russell 2500 Value Index 16.83% 16.83% 87.47% 10.88% 12.15% 10.23% 9.24%
CRM Mid Cap Value  
CRIMX - Institutional Shares 10.63% 10.63% 66.63% 12.22% 14.00% 10.78% 11.56% January 6, 1998 0.97% 0.97%
CRMMX - Investor Shares 10.55% 10.55% 66.32% 11.99% 13.77% 10.56% 10.72% September 20, 2000 1.17% 1.17%
Russell Midcap Value Index 13.05% 13.05% 73.76% 10.70% 11.60% 11.05% 9.62%
CRM All Cap Value  
CRIEX - Institutional Shares 9.16% 9.16% 78.07% 10.52% 12.20% 9.52% 7.42% October 24, 2006 1.21% 1.26%
CRMEX - Investor Shares 9.14% 9.14% 77.89% 10.23% 11.92% 9.25% 7.16% October 24, 2006 1.46% 1.51%
Russell 3000 Value Index 11.89% 11.89% 58.38% 10.99% 11.87% 10.91% 7.28%

Month-End

as of March 31, 2021
Our Funds MAR'21 YTD 1YR 3YR 5YR 10YR Since Inception2 Inception Date Net Expense Ratio Gross Expense Ratio1
 
CRIHX – Institutional Shares 1.56% 1.82% 33.00% 8.34% 6.05%
S&P 500 Index 4.38% 6.17% 56.35% 16.78% 16.12%
 
CRISX - Institutional Shares 3.03% 15.30% 81.89% 7.46% 10.87% 8.76% 9.07%
CRMSX - Investor Shares 2.98% 15.24% 81.45% 7.21% 10.62% 8.52% 10.46%
Russell 2000 Value Index 5.23% 21.17% 97.05% 11.57% 13.56% 10.06% 10.10%
 
CRIAX - Institutional Shares 5.37% 13.50% 82.62% 14.39% 14.59% 10.74% 10.32%
CRMAX - Investor Shares 5.40% 13.44% 82.13% 14.12% 14.35% 10.51% 10.09%
Russell 2500 Value Index 4.96% 16.83% 87.47% 10.88% 12.15% 10.23% 9.24%
 
CRIMX - Institutional Shares 5.79% 10.63% 66.63% 12.22% 14.00% 10.78% 11.56%
CRMMX - Investor Shares 5.77% 10.55% 66.32% 11.99% 13.77% 10.56% 10.72%
Russell Midcap Value Index 5.16% 13.05% 73.76% 10.70% 11.60% 11.05% 9.62%
 
CRIEX - Institutional Shares 3.12% 9.16% 78.07% 10.52% 12.20% 9.52% 7.42%
CRMEX - Investor Shares 3.08% 9.14% 77.89% 10.23% 11.92% 9.25% 7.16%
Russell 3000 Value Index 5.84% 11.89% 58.38% 10.99% 11.87% 10.91% 7.28%

Daily

as of April 16, 2021
Our Funds Current Price Change YTD Inception Date Net Expense Ratio Gross Expense Ratio1
CRM Long/Short Opportunities  
CRIHX - Institutional Shares 11.9 0.76 3.39 August 16, 2016 2.96% 3.04%
CRM Small Cap Value  
CRISX - Institutional Shares 20.58 0.98 18.34 January 27, 1998 0.93% 0.93%
CRMSX - Investor Shares 17.38 0.93 18.23 October 1, 1995 1.17% 1.17%
CRM Small/Mid Cap Value  
CRIAX - Institutional Shares 15.17 1.07 17.05 September 1, 2004 0.96% 0.96%
CRMAX - Investor Shares 14.71 1.17 17.02 September 1, 2004 1.18% 1.18%
CRM Mid Cap Value  
CRIMX - Institutional Shares 27.71 0.36 14.17 January 6, 1998 0.97% 0.97%
CRMMX - Investor Shares 26.49 0.38 14.08 September 20, 2000 1.17% 1.17%
CRM All Cap Value  
CRIEX - Institutional Shares 8.87 0.34 12.85 October 24, 2006 1.21% 1.26%
CRMEX - Investor Shares 8.64 0.35 12.79 October 24, 2006 1.46% 1.51%

Shares of CRM Funds are distributed by ALPS Distributors, Inc.

Cramer Rosenthal McGlynn, LLC is the investment advisor to the CRM Funds and is not affiliated with ALPS.

The information on the Funds’ performance represent past performance, which does not guarantee future results. If you invest in a Fund, your investment return and principal value will fluctuate, so that your shares, when redeemed, may be worth more of less than their original cost. The Funds’ current performance may be lower or higher than the performance above. For most recent month-end performance, please click here.

1The net expense ratios are the current annualized expense ratio as stated in the CRM Funds prospectus dated October 28, 2019,  for the CRM Long/Short Opportunities Fund, CRM Small Cap Value Fund, CRM Small/Mid Cap Value Fund, CRM Mid Cap Value Fund, and CRM All Cap Value Fund, and will fluctuate over time. CRM has a contractual obligation to waive a portion of its fees through November 1, 2020 and to assume certain expenses of the CRM Long/Short Opportunities Fund to the extent that the total annual fund operating expenses, excluding taxes, extraordinary expenses, brokerage commissions, interest, dividend and interest expenses related to short sales, and acquired fund fees and expenses, exceed 1.60% of average daily net assets of Institutional Shares, and may be terminated by a vote of the Board of Trustees. CRM has a contractual obligation to waive a portion of fees and to assume certain expense of the CRM All Cap Value Fund to the extent that the total annual fund operating expenses, excluding taxes, extraordinary expenses, brokerage commissions, interest and acquired fund fees and expenses, exceed 1.45% and 1.20% of average daily net assets of Investor Shares and Institutional Shares, respectively. These expense limitations are in effect until November 1, 2020. Prior to that date, the arrangement may be terminated for a class only by the vote of the Board of Trustees of the Fund. Performance would have been lower in the absence of fee waivers and expense reimbursements. 2 The Since Inception performance return for the indices represent the Investor Shares for the CRM Small Cap Value Fund and the Institutional Shares for the CRM Long/Short Opportunities Fund, CRM Small/Mid Cap Value Fund, CRM Mid Cap Value Fund, and CRM All Cap Value Fund. For the index performance information for all other share classes, please see the performance listed for each Fund at CRM Funds.